Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellitus

被引：2
|
作者：
Zhito, Alexey, V [1 ]
Iusupova, Alfia O. [1 ]
Privalova, Elena, V [1 ]
Khabarova, Natalia, V [1 ]
Belenkov, Yurii N. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Sechenov Univ, Trubetskaya Ul 8-2, Moscow 119991, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2019年 / 15卷 / 06期
关键词：
ischemic heart disease; diabetes mellitus type 2; E-selectin; von Willebrand factor; endothelin-1; endothelial dysfunction; SOLUBLE E-SELECTIN; CIRCULATING ADHESION MOLECULES; ARTERY-DISEASE; INFLAMMATORY MARKERS; P-SELECTIN; GLUCOSE; ASSOCIATION; RISK; BIOMARKERS; DIAGNOSIS;
D O I：
10.20996/1819-6446-2019-15-6-892-899
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The prevalence of coronary heart disease (CHD) and type 2 diabetes mellitus (type 2 diabetes) in Russia and in the world continues to increase. Despite the prevention and optimization of therapy, CHD retains its leadership among all causes of death, and the mortality rate from type 2 diabetes and its complications gradually increases too. To improve the treatment of the above mentioned diseases, it is necessary to clarify the pathogenetic mechanisms of their development. The formation of endothelial dysfunction, characterized by an increase in the level of cell adhesion molecules and vasoconstriction, is a common link characteristic for the course and progression of CHD and type 2 diabetes. This article presents an analysis of pre-and clinical studies on the role of endothelial dysfunction markers: cell adhesion molecules (E-selectin), vasoconstriction (endothelin-1) and von Willebrand factor in patients with CHD, including those with type 2 diabetes mellitus.
引用
收藏
页码：892 / 899
页数：8
相关论文
共 50 条
  • [31] Correction of hyperglycaemia reduces insulin resistance and sevum soluble E-selectin levels in patients with Type 2 diabetes mellitus
    Matsumoto, K
    Nakamura, H
    Ueki, Y
    Tominga, T
    Miyake, S
    DIABETIC MEDICINE, 2001, 18 (03) : 224 - 228
  • [32] Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus
    Statsenko, M. E.
    Derevyanchenko, M. V.
    Ostrovsky, O. V.
    Titarenko, M. N.
    Shvets, M. K.
    Bondarev, A. M.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (09) : 63 - 68
  • [33] Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
    Perumalsamy, Sangeetha
    Huri, Hasniza Zaman
    Abdullah, Bashar Mudhaffar
    Mazlan, Othman
    Ahmad, Wan Azman Wan
    Vethakkan, Shireene Ratna D. B.
    METABOLITES, 2023, 13 (03)
  • [34] Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus
    Kado, S
    Nagata, N
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 46 (02) : 143 - 148
  • [35] Effect of nicardipine versus enalapril on plasma endothelin-1 in hypertensive patients with type 2 diabetes mellitus
    Iwase, M
    Doi, Y
    Goto, D
    Ichikawa, K
    Iino, K
    Yoshinari, M
    Fujishima, M
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2000, 22 (7-8) : 695 - 703
  • [36] Association analysis between endothelial function related factors and coronary artery stenosis degree in coronary heart disease patients with type 2 diabetes mellitus
    Li, Quanmin
    Zhang, Zhifang
    Du, Ruiqin
    Hu, Xiaoqiang
    Yan, Yan
    Gao, Qing
    Fan, Yanting
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2012, 25 (7-8) : 711 - 716
  • [37] The association of inflammatory markers and periodontal indexes with the risk of coronary heart disease in Chinese patients with type 2 diabetes mellitus
    Chen, Ling
    Wei, Bin
    Xu, Liang
    Wu, Yun
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 135 : 37 - 44
  • [38] Effect of rosuvastatin on vascular endothelial functions and inflammatory factors of patients with type 2 diabetes mellitus and coronary heart disease
    Ma, Gang
    Bi, Shuting
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (01) : 332 - 336
  • [39] Effect of PPAR-γ agonist treatment on markers of endothelial dysfunction in patients with type 2 diabetes mellitus
    Dolezalova, R.
    Haluzik, M. M.
    Bosanska, L.
    Lacinova, Z.
    Kasalova, Z.
    Stulc, T.
    Haluzik, M.
    PHYSIOLOGICAL RESEARCH, 2007, 56 (06) : 741 - 748
  • [40] Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)
    Budde, U.
    Schneppenheim, R.
    Eikenboom, J. .
    Goodeve, A.
    Will, K.
    Drewke, E.
    Castaman, G.
    Rodeghiero, F.
    Federici, A. B.
    Batlle, J. .
    Perez, A.
    Meyer, D.
    Mazurier, C.
    Goudemand, J.
    Ingerslev, J.
    Habart, D.
    Vorlova, Z.
    Holmberg, L.
    Lethagen, S.
    Pasi, J.
    Hill, F.
    Peake, I.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (05) : 762 - 771
12345